ALIBABA-W (09988.HK): Spin-off of T-Head for Main Board Listing Confirmed by HKEX
NewTimeSpace News: On 10 November 2026, Alibaba Group Holding Limited (stock codes: 9988 and 89988) announced that, under Practice Note 15 of the Listing Rules, it has submitted to the Stock Exchange a proposal to spin off and separately list its wholly-owned subsidiary, T-Head (Shanghai) Technology Co., Ltd. (平头哥), and that the Stock Exchange has confirmed the spin-off may proceed.
T-Head confidentially submitted an A1 listing application form to the Stock Exchange on 11 September 2026 seeking approval for the listing and trading of its H shares on the Main Board. The spin-off is intended to be effected through a global offering of T-Head H shares, comprising a Hong Kong public offer for subscription by the public and a placing to institutional and professional investors. As at the date of the announcement, T-Head is a wholly-owned subsidiary of the Company and a leading full-stack data centre chip supplier in China; it is expected to remain a subsidiary after completion.
Details of the spin-off, including the size and structure of the global offering and the reduction in the Company's shareholding in T-Head, have not been finalised. As the highest applicable percentage ratio is expected to be below 5%, the spin-off will not constitute a discloseable transaction and is not expected to affect the Company's dual primary listing status on the Stock Exchange and the NYSE.
The Company applied for, and the Stock Exchange granted, a waiver from strict compliance with paragraph 3(f) of Practice Note 15 on assured entitlements to T-Head H shares, citing US securities registration requirements, PRC legal restrictions and lock-ups on pre-offering shares, and the immateriality of the spin-off to the Company's assets, revenue and net profit. The spin-off remains subject to Listing Committee approval, CSRC filing and final decisions by the Company and T-Head.
- KNT HOLDINGS (01025.HK): Tsuen Wan Property Sale to Book HK$7.42m Net Loss
- CDB LEASING (01606.HK): RMB3.67bn IT Equipment Purchase a Discloseable Transaction
- GOFINTECH QUANT (00290.HK): Clarifies VATP Spending; Extra HK$23.4m Redirected to Quantum
- TIANGONG INT'L (00826.HK): Subsidiary TG TECH to Unlock 15.25m Shares on 13 November
- SIMCERE PHARMA (02096.HK): SIM0725 Cleared for Clinical Trial in Autoimmune Diseases